Clinical study of efficacy of pregabalin for peripheral neuropathic pain in patients with lumbar spinal stenosis

Clinical study of efficacy of pregabalin for peripheral neuropathic pain in patients with lumbar spinal stenosis - Clinical study of efficacy of pregabalin for peripheral neuropathic pain in patients with lumbar spinal stenosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017743

Enrollment

Registered

2015-05-30

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral neuropathic pain in patients with lumbar spinal stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.20 years of age or 90 years of age or less 2.Diagnosed by spinal canal stenosis and MRI 3.More than one month of treatment with NSAID implementation 4.The baseline Numerical rating scale NRS 3 5.with normal renal function example creatinine clearance 60ml / min 6.Neuropathic pain screening questionnaire 6 7.leg pain 8.For this study participants that document consent of the person or Daidaku who has been obtained

Exclusion criteria

Exclusion criteria: 1.Antidepressants, anti-epileptic drugs, it has been taking opioid 2.Registered before it conducted a nerve block within one month 3.To have, serious complications 4.Pregnancy / nursing women 5.The plan to epidural anesthesia within 6 weeks 6.Peripheral vascular disorders 7.Past history of malignancy within two years 8.Have a history of, spinal canal stenosis surgery 9.And other, cases attending physician was deemed inappropriate

Design outcomes

Primary

Measure	Time frame
Comparison of pain NRS after baseline and pregabalin administered 6 weeks	—

Secondary

Measure	Time frame
1.after the baseline and pregabalin administration six weeks of the JOA Back Pain Evaluation Questionnaire 2.Comparison of sleep NRS after baseline and pregabalin administered 6 weeks 3.Comparison of intermittent claudication after baseline and pregabalin administered 6 weeks	—

Countries

Japan

Contacts

Public ContactSeiji Ohtori

Graduate school of medicine, Department of Orthopaedic Surgery

sohtri@faculty.chiba-u.jp0432262117

Outcome results